Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potentially Inappropriate Treatments in Turkish ICUs: Point Prevalence Study

NCT03520270 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03520270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potentially Inappropriate Treatments in Turkish ICUs: Point Prevalence Study
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
October 15, 2018
Completion date
November 30, 2018
Enrollment
1,128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, potentially inappropriate medication list, terminal illness